SCHEMBL4533683

SCHEMBL4533683

Nc1cc(-c2ccc(Cl)c(Cl)c2)cs1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AHR P35869 5/20 0.56
CYP1B1 Q16678 1/20 0.48
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 2/20 0.44
MAPT P10636 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
CYP3A4 P08684 3/20 0.43
TSHR P16473 2/20 0.43
MAPK1 P28482 1/20 0.43
ABL1 P00519 1/20 0.42
PRKCZ Q05513 3/20 0.41
KMO O15229 3/20 0.41
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
DHFR P00374 1/20 0.39
IKBKB O14920 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25694241 0.83 ABL1 (0.40) AHRCYP1B1ALDH1A1NPC1RAB9A
SCHEMBL25694246 0.83 EPHB4 (0.51) ALDH1A1CYP3A4TSHRMAPK1ABL1
SCHEMBL10151048 0.79 ALAD (0.52) AHRALDH1A1KDM4EMAPTL3MBTL1
Hydrochloric Acid SCHEMBL12465675 0.78 ALAD (0.50) AHRALDH1A1KDM4EMAPTL3MBTL1
SCHEMBL25736153 0.76 AHR (0.56) AHRCYP1B1ALDH1A1KDM4EMAPT
SCHEMBL137915 0.75 AHR (1.00) AHRCYP1B1ALDH1A1KDM4EMAPT
SCHEMBL29769221 0.75 AHR (1.00) AHRCYP1B1ALDH1A1KDM4EMAPT
SCHEMBL23539914 0.74 TAAR1 (0.47) ALDH1A1DHFR
Hydrochloric Acid SCHEMBL12466012 0.73 TAAR1 (0.46) ALDH1A1DHFR
SCHEMBL438812 0.73 CCNC (0.43) MAPTNPC1RAB9ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 EP disclosed
US-20130303521-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES HYDRA BIOSCIENCES, INC (US) 2013-11-14 US disclosed
US-20130165427-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES HYDRA BIOSCIENCES, INC. (US) 2013-06-27 US disclosed
US-20130059869-A1 METHODS AND COMPOSITIONS FOR TREATING DISORDERS HYDRA BIOSCIENCES, INC. 2013-03-07 US disclosed
US-20120108614-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES HYDRA BIOSCIENCES, INC. 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108614-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES ELANE, CASP3, MMP8 AHR 1071/4885CYP1B1 1271/4885ALDH1A1 1104/4885
US-20130303521-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES ELANE, CASP3, MMP8 AHR 1071/4885CYP1B1 1271/4885ALDH1A1 1104/4885
US-20130165427-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES ELANE, CASP3, MMP8 AHR 1071/4885CYP1B1 1271/4885ALDH1A1 1104/4885
US-20130059869-A1 METHODS AND COMPOSITIONS FOR TREATING DISORDERS TRPA1, TRPV1, TRPV3 AHR 535/4885CYP1B1 1355/4885ALDH1A1 968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.